Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome
- PMID: 14690147
- DOI: 10.1080/03009740310003974
Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome
Abstract
Chronic infantile neurological cutaneous articular (CINCA) syndrome is a rare disorder of unknown aetiology with neonatal onset, characterized by severe arthropathy, persistent skin rash and central nervous system disease. Joint involvement may vary from minimal swelling to destructive arthritis, with inability to stand or walk. The most striking findings of CINCA syndrome are cartilage anomalies with epiphyseal modifications and abnormal ossification, for which a pathogenetic role of tumour necrosis factor-alpha (TNF-alpha) is postulated. We describe a 4-year-old child affected with CINCA syndrome and presenting progressive joint disease, in whom non-steroidal anti-inflammatory drugs (NSAID) and systemic corticosteroidal therapy had been ineffective. Etanercept, anti-TNF-alpha therapy, was administered over a 6-month-period resulting in a dramatic improvement of the arthropathy. This good response to anti-cytokine treatment supports our hypothesis that TNF-alpha might play an important role in the pathogenesis of CINCA syndrome, which needs to be evaluated and confirmed in further studies.
Similar articles
-
A severe case of chronic infantile neurologic, cutaneous, articular syndrome treated with biologic agents.Arthritis Rheum. 2006 Jul;54(7):2314-20. doi: 10.1002/art.21965. Arthritis Rheum. 2006. PMID: 16802372
-
Treatment of patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome: comment on the article by Matsubara et al.Arthritis Rheum. 2007 Jun;56(6):2099-101; author reply 2101-2. doi: 10.1002/art.22561. Arthritis Rheum. 2007. PMID: 17530657 No abstract available.
-
Effective co-administration of infliximab and etanercept following the failure of sequential anti-TNF agents in a patient with HLA-B27-associated arthropathy.Rheumatology (Oxford). 2006 Oct;45(10):1314-5. doi: 10.1093/rheumatology/kel211. Epub 2006 Jul 11. Rheumatology (Oxford). 2006. PMID: 16837474 No abstract available.
-
TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.BioDrugs. 2005;19(1):47-57. doi: 10.2165/00063030-200519010-00006. BioDrugs. 2005. PMID: 15691217 Review.
-
TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.Int J Dermatol. 2011 May;50(5):619-25. doi: 10.1111/j.1365-4632.2011.04871.x. Int J Dermatol. 2011. PMID: 21506984 Review.
Cited by
-
Lights and shadows in autoinflammatory syndromes from the childhood and adulthood perspective.Clin Rheumatol. 2016 Mar;35(3):565-72. doi: 10.1007/s10067-015-3132-6. Epub 2015 Dec 3. Clin Rheumatol. 2016. PMID: 26631101 Review.
-
The Broad-Ranging Panorama of Systemic Autoinflammatory Disorders with Specific Focus on Acute Painful Symptoms and Hematologic Manifestations in Children.Mediterr J Hematol Infect Dis. 2018 Nov 1;10(1):e2018067. doi: 10.4084/MJHID.2018.067. eCollection 2018. Mediterr J Hematol Infect Dis. 2018. PMID: 30416699 Free PMC article. Review.
-
Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases.Mediators Inflamm. 2019 Dec 31;2019:3293145. doi: 10.1155/2019/3293145. eCollection 2019. Mediators Inflamm. 2019. PMID: 32082075 Free PMC article. Review.
-
Resolution of femoral metaphyseal dysplasia in CINCA syndrome after long-term treatment with interleukin-1 blockade.Clin Rheumatol. 2018 Jul;37(7):2007-2009. doi: 10.1007/s10067-018-4145-8. Epub 2018 May 16. Clin Rheumatol. 2018. PMID: 29766377 Review.
-
Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS).Biologics. 2010 May 25;4:131-8. doi: 10.2147/btt.s7580. Biologics. 2010. PMID: 20531965 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical